These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32012274)

  • 1. Exploratory analysis of anti-insulin antibodies in diabetic dogs receiving recombinant human insulin.
    Lester M; O'Kell AL
    J Small Anim Pract; 2020 Apr; 61(4):236-240. PubMed ID: 32012274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breed differences in development of anti-insulin antibodies in diabetic dogs and investigation of the role of dog leukocyte antigen (DLA) genes.
    Holder AL; Kennedy LJ; Ollier WE; Catchpole B
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):130-8. PubMed ID: 26272177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-insulin antibodies in dogs with naturally occurring diabetes mellitus.
    Davison LJ; Ristic JM; Herrtage ME; Ramsey IK; Catchpole B
    Vet Immunol Immunopathol; 2003 Jan; 91(1):53-60. PubMed ID: 12507850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations.
    Davison LJ; Walding B; Herrtage ME; Catchpole B
    J Vet Intern Med; 2008; 22(6):1317-25. PubMed ID: 18976287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of type of starch and feeding management on glycaemic control in diabetic dogs.
    Teshima E; Brunetto MA; Teixeira FA; Gomes MOS; Lucas SRR; Pereira GT; Carciofi AC
    J Anim Physiol Anim Nutr (Berl); 2021 Nov; 105(6):1192-1202. PubMed ID: 33904623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta cell and insulin antibodies in treated and untreated diabetic cats.
    Hoenig M; Reusch C; Peterson ME
    Vet Immunol Immunopathol; 2000 Nov; 77(1-2):93-102. PubMed ID: 11068068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Owner preference for insulin delivery device and glycaemic control in diabetic dogs.
    Del Baldo F; Colajanni L; Corradini S; Palagiano P; Di Cunzolo A; Perissinotto L; Drudi I; Horspool L; Fracassi F
    J Small Anim Pract; 2023 Apr; 64(4):255-264. PubMed ID: 36316285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.
    Fracassi F; Linari G; Del Baldo F; Di Cunzolo A; D'Angelo S; Malerba E; Carotenuto G; Bonfanti U; Corradini S
    Vet Rec; 2018 Sep; 183(8):262. PubMed ID: 30030413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to recombinant canine proinsulin in canine diabetic patients.
    Davison LJ; Herrtage ME; Catchpole B
    Res Vet Sci; 2011 Aug; 91(1):58-63. PubMed ID: 20855094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus.
    Palm CA; Boston RC; Refsal KR; Hess RS
    J Vet Intern Med; 2009; 23(1):50-5. PubMed ID: 19175720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an insulin zinc suspension for control of naturally occurring diabetes mellitus in dogs.
    Horn B; Mitten RW
    Aust Vet J; 2000 Dec; 78(12):831-4. PubMed ID: 11194469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of insulin glargine in dogs with diabetes mellitus.
    Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
    Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
    J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma insulin, glucagon, and nonesterified fatty acids in dogs with diabetes mellitus.
    Manns JG; Martin CL
    Am J Vet Res; 1972 May; 33(5):981-5. PubMed ID: 5023056
    [No Abstract]   [Full Text] [Related]  

  • 16. Detemir insulin for the treatment of diabetes mellitus in dogs.
    Fracassi F; Corradini S; Hafner M; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    J Am Vet Med Assoc; 2015 Jul; 247(1):73-8. PubMed ID: 26086231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Currently available insulin preparations for use in the dog and cat.
    Kintzer PP
    Semin Vet Med Surg Small Anim; 1997 Nov; 12(4):236-8. PubMed ID: 10889871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitus.
    Durocher LL; Hinchcliff KW; DiBartola SP; Johnson SE
    J Am Vet Med Assoc; 2008 May; 232(9):1310-20. PubMed ID: 18447775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998).
    Hess RS; Ward CR
    J Am Vet Med Assoc; 2000 Jan; 216(2):217-21. PubMed ID: 10649757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon stimulation test for estimating endogenous insulin secretion in dogs.
    Fall T; Holm B; Karlsson A; Ahlgren KM; Kämpe O; von Euler H
    Vet Rec; 2008 Aug; 163(9):266-70. PubMed ID: 18757903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.